The glucocorticoid receptor in inflammatory processes: Transrepression is not enough

Biological Chemistry

Volumn 396, Issue 11, 2015, Pages 1223-1231

  Hübner, Sabine ^a   Dejager, Lien ^b   Libert, Claude ^b   Tuckermann, Jan P ^a  

^a UNIVERSITY OF ULM   (Germany)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

ChIP Seq; glucocorticoid receptor; inflammation; transactivation; transgenic mice; transrepression

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR; LIGAND;

ANTIINFLAMMATORY ACTIVITY; DIMERIZATION; GENE CONTROL; GENE REPRESSION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION; ANIMAL; DOWN REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; TRANSCRIPTION INITIATION;

ANIMALS; DOWN-REGULATION; HUMANS; INFLAMMATION; LIGANDS; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTIONAL ACTIVATION;

EID: 84945242540     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2015-0106     Document Type: Review

References (66)

1. Abraham, S.M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., Clark, A.R. (2006). Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203, 1883-1889.
2. Ayroldi, E., Riccardi, C. (2009). Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23, 3649-3658.
3. Ayroldi, E., Migliorati, G., Bruscoli, S., Marchetti, C., Zollo, O., Cannarile, L., D'Adamio, F., Riccardiand, C. (2001). Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98, 743-753.
4. Baschant, U., Frappart, L., Rauchhaus, U., Bruns, L., Reichardt, H.M., Kamradt, T., Brauer, R., Tuckermann, J.P. (2011). Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc. Natl. Acad. Sci. USA 108, 19317-19322.
5. Baschant, U., Lane, N.E., Tuckermann, J. (2012). The multiple facets of glucocorticoid action in rheumatoid arthritis. Nat. Rev. Rheumatol. 8, 645-655.
6. Bhattacharyya, S., Brown, D.E., Brewer, J.A., Vogt, S.K., Muglia, L.J. (2007). Macrophage glucocorticoid receptors regulate Tolllike receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109, 4313-4319.
7. Bhattacharyya, S., Ratajczak, C.K., Vogt, S.K., Kelley, C., Colonna, M., Schreiber, R.D., Muglia, L.J. (2010). TAK1 targeting by glucocorticoids determines JNK and IkappaB regulation in Tolllike receptor-stimulated macrophages. Blood 115, 1921-1931.
8. Biddie, S.C., John, S., Sabo, P.J., Thurman, R.E., Johnson, T.A., Schiltz, R.L., Miranda, T.B., Sung, M.H., Trump, S., Lightman, S.L., et al. (2011). Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 43, 145-155.
9. Bledsoe, R.K., Montana, V.G., Stanley, T.B., Delves, C.J., Apolito, C.J., McKee, D.D., Consler, T.G., Parks, D.J., Stewart, E.L., Willson, T.M., et al. (2002). Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110, 93-105.
10. Chen, D., Ma, H., Hong, H., Koh, S.S., Huang, S.M., Schurter, B.T., Aswad, D.W., Stallcup, M.R. (1999). Regulation of transcription by a protein methyltransferase. Science 284, 2174-2177.
11. Clark, A.R. (2007). Anti-inflammatory functions of glucocorticoidinduced genes. Mol. Cell. Endocrinol. 275, 79-97.
12. Clark, A.R., Lasa, M. (2003). Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr. Opin. Pharmacol. 3, 404-411.
13. De Bosscher, K., Haegeman, G., Elewaut, D. (2010). Targeting inflammation using selective glucocorticoid receptor modulators. Curr. Opin. Pharmacol. 10, 497-504.
14. Finan, B., Yang, B., Ottaway, N., Stemmer, K., Muller, T.D., Yi, C.X., Habegger, K., Schriever, S.C., Garcia-Caceres, C., Kabra, D.G., et al. (2012). Targeted estrogen delivery reverses the metabolic syndrome. Nat. Med. 18, 1847-1856.
15. Flammer, J.R., Dobrovolna, J., Kennedy, M.A., Chinenov, Y., Glass, C.K., Ivashkiv, L.B., Rogatsky, I. (2010). The type I interferon signaling pathway is a target for glucocorticoid inhibition. Mol. Cell. Biol. 30, 4564-4574.
16. Frijters, R., Fleuren, W., Toonen, E.J., Tuckermann, J.P., Reichardt, H.M., van der Maaden, H., van Elsas, A., van Lierop, M.J., Dokter, W., de Vlieg, J. et al. (2010). Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. BMC Genomics 11, 359.
17. Gebhardt, J.C., Suter, D.M., Roy, R., Zhao, Z.W., Chapman, A.R., Basu, S., Maniatis, T., Xie, X.S. (2013). Single-molecule imaging of transcription factor binding to DNA in live mammalian cells. Nat. Methods 10, 421-426.
18. Granfeldt, A., Hvas, C.L., Graversen, J.H., Christensen, P.A., Petersen, M.D., Anton, G., Svendsen, P., Solling, C., Etzerodt, A., Tonnesen, E., et al. (2013). Targeting dexamethasone to macrophages in a porcine endotoxemic model. Crit. Care Med. 41, E309-E318.
19. Grontved, L., John, S., Baek, S., Liu, Y., Buckley, J.R., Vinson, C., Aguilera, G., Hager, G.L. (2013). C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. EMBO J. 32, 1568-1583.
20. Hammer, M., Echtenachter, B., Weighardt, H., Jozefowski, K., Rose-John, S., Mannel, D.N., Holzmann, B., Lang, R. (2010). Increased inflammation and lethality of Dusp1-/-mice in polymicrobial peritonitis models. Immunology 131, 395-404.
21. Hannon, R., Croxtall, J.D., Getting, S.J., Roviezzo, F., Yona, S., Paul-Clark, M.J., Gavins, F.N., Perretti, M., Morris, J.F., Buckingham, J.C. et al. (2003). Aberrant inflammation and resistance to glucocorticoids in annexin 1-/-mouse. FASEB J. 17, 253-255.
22. Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H.J., Herrlich, P., Cato, A.C.B. (1994). A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor Ap-1. EMBO J. 13, 4087-4095.
23. Hübner, S., Tuckermann, J. (2012). Molecular mechanisms of the glucocorticoid receptor in steroid therapy-lessons from transgenic mice. Biomol. Concepts 3, 241-253.
24. Jewell, C.M., Scoltock, A.B., Hamel, B.L., Yudt, M.R., Cidlowski, J.A. (2012). Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells. Mol. Endocrinol. 26, 244-256.
25. John, S., Sabo, P.J., Thurman, R.E., Sung, M.H., Biddie, S.C., Johnson, T.A., Hager, G.L., Stamatoyannopoulos, J.A. (2011). Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 43, 264-268.
26. Kino, T., Manoli, I., Kelkar, S., Wang, Y., Su, Y.A., Chrousos, G.P. (2009). Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. Biochem. Biophys. Res. Commun. 381, 671-675.
27. Kleiman, A., Tuckermann, J.P. (2007). Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Mol. Cell. Endocrinol. 275, 98-108.
28. Kleiman, A., Hübner, S., Rodriguez Parkitna, J.M., Neumann, A., Hofer, S., Weigand, M.A., Bauer, M., Schmid, W., Schutz, G., Libert, C., et al. (2012). Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J. 26, 722-729.
29. Lim H., Uhlenhaut N.H., Rauch A., Weiner J., Hübner S., Hübner N., Won J., Lazar M.A., Tuckermann, J., Steger D.J. (2015). Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo. Genome Res. in press.
30. Ma, H., Baumann, C.T., Li, H., Strahl, B.D., Rice, R., Jelinek, M.A., Aswad, D.W., Allis, C.D., Hager, G.L., Stallcup, M.R. (2001). Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter. Curr. Biol. 11, 1981-1985.
31. Meijsing, S.H., Pufall, M.A., So, A.Y., Bates, D.L., Chen, L., Yamamoto, K.R. (2009). DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324, 407-410.
32. Nicolaides, N.C., Galata, Z., Kino, T., Chrousos, G.P., Charmandari, E. (2010). The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75, 1-12.
33. Nixon, M., rew, R., Chapman, K.E. (2013). It takes two to tango: dimerisation of glucocorticoid receptor and its antiinflammatory functions. Steroids 78, 59-68.
34. Oakley, R.H., Cidlowski, J.A. (2011). Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 286, 3177-3184.
35. Pinheiro, I., Dejager, L., Petta, I., Vandevyver, S., Puimege, L., Mahieu, T., Ballegeer, M., Van Hauwermeiren, F., Riccardi, C., Vuylsteke, M. et al. (2013). LPS resistance of SPRET/Ei mice is mediated by Gilz, encoded by the Tsc22d3 gene on the X chromosome. EMBO Mol. Med. 5, 456-470.
36. Presman, D.M., Ogara, M.F., Stortz, M., Alvarez, L.D., Pooley, J.R., Schiltz, R.L., Grontved, L., Johnson, T.A., Mittelstadt, P.R., Ashwell, J.D., et al. (2014). Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor. PLoS Biol. 12, e1001813.
37. Rao, N.A., McCalman, M.T., Moulos, P., Francoijs, K.J., Chatziioannou, A., Kolisis, F.N., Alexis, M.N., Mitsiou, D.J., Stunnenberg, H.G. (2011). Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes. Genome Res. 21, 1404-1416.
38. Rapicavoli, N.A., Qu, K., Zhang, J.J., Mikhail, M., Laberge, R.M., Chang, H.Y. (2013). A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife. 2, e00762.
39. Ratman, D., Vanden Berghe, W., Dejager, L., Libert, C., Tavernier, J., Beck, I.M., De Bosscher, K. (2013). How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Mol. Cell. Endocrinol. 380, 41-54.
40. Rauch, A., Seitz, S., Baschant, U., Schilling, A.F., Illing, A., Stride, B., Kirilov, M., Mandic, V., Takacz, A., Schmidt-Ullrich, R., et al. (2010). Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 11, 517-531.
41. Reddy, T.E., Pauli, F., Sprouse, R.O., Neff, N.F., Newberry, K.M., Garabedian, M.J., Myers, R.M. (2009). Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 19, 2163-2171.
42. Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P. et al. (1998). DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541.
43. Reichardt, H.M., Tuckermann, J.P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., Schutz, G. (2001). Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20, 7168-7173.
44. Rosenfeld, M.G., Lunyak, V.V., Glass, C.K. (2006). Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20, 1405-1428.
45. Salojin, K.V., Owusu, I.B., Millerchip, K.A., Potter, M., Platt, K.A., Oravecz, T. (2006). Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176, 1899-1907.
46. Savory, J.G., Prefontaine, G.G., Lamprecht, C., Liao, M., Walther, R.F., Lefebvre, Y.A., Hache, R.J. (2001). Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Mol. Cell. Biol. 21, 781-793.
47. Schacke, H., Berger, M., Rehwinkel, H., Asadullah, K. (2007). Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index. Mol. Cell Endocrinol. 275, 109-117.
48. Schiller, B.J., Chodankar, R., Watson, L.C., Stallcup, M.R., Yamamoto, K.R. (2014). Glucocorticoid receptor binds half sites as a monomer and regulates specific target genes. Genome Biol. 15, 418.
49. Schweingruber, N., Haine, A., Tiede, K., Karabinskaya, A., van den Brandt, J., Wust, S., Metselaar, J.M., Gold, R., Tuckermann, J.P., Reichardt, H.M., et al. (2011). Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis. J. Immunol. 187, 4310-4318.
50. Schweingruber, N., Fischer, H.J., Fischer, L., van den Brandt, J., Karabinskaya, A., Labi, V., Villunger, A., Kretzschmar, B., Huppke, P., Simons, M., et al. (2014). Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses. Acta Neuropathol. 127, 713-729.
51. Siersbaek, R., Nielsen, R., John, S., Sung, M.H., Baek, S., Loft, A., Hager, G.L., Mandrup, S. (2011). Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 30, 1459-1472.
52. Silverman, M.N., Mukhopadhyay, P., Belyavskaya, E., Tonelli, L.H., Revenis, B.D., Doran, J.H., Ballard, B.E., Tam, J., Pacher, P., Sternberg, E.M. (2013). Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice. Mol. Psychiatry 18, 1006-1017.
53. Starick, S.R., Ibn-Salem, J., Jurk, M., Hernandez, C., Love, M.I., Chung, H.R., Vingron, M., Thomas-Chollier, M., Meijsing, S.H. (2015). ChIP-exo signal associated with DNA-binding motifs provide insights into the genomic binding of the glucocorticoid receptor and cooperating transcription factors. Genome Res. DOI:10.1101/gr.185157.114.
54. Surjit, M., Ganti, K.P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., Chambon, P. (2011). Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145, 224-241.
55. Tronche, F., Opherk, C., Moriggl, R., Kellendonk, C., Reimann, A., Schwake, L., Reichardt, H.M., Stangl, K., Gau, D., Hoeflich, A., et al. (2004). Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev. 18, 492-497.
56. Tuckermann, J.P., Kleiman, A., Moriggl, R., Spanbroek, R., Neumann, A., Illing, A., Clausen, B.E., Stride, B., Forster, I., Habenicht, A.J., et al. (2007). Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J. Clin. Invest. 117, 1381-1390.
57. Uhlenhaut, N.H., Barish, G.D., Yu, R.T., Downes, M., Karunasiri, M., Liddle, C., Schwalie, P., Hübner, N., Evans, R.M. (2013). Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol. Cell 49, 158-171.
58. Vandevyver, S., Dejager, L., Libert, C. (2012a). On the trail of the glucocorticoid receptor: into the nucleus and back. Traffic 13, 364-374.
59. Vandevyver, S., Dejager, L., Van Bogaert, T., Kleyman, A., Liu, Y., Tuckermann, J., Libert, C. (2012b). Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. J. Clin. Invest. 122, 2130-2140.
60. Vandevyver, S., Dejager, L., Tuckermann, J., Libert, C. (2013). New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptormediated transactivation. Endocrinology 154, 993-1007.
61. Vandevyver, S., Dejager, L., Libert, C. (2014). Comprehensive overview of the structure and regulation of the glucocorticoid receptor. Endocr. Rev. 35, 671-693.
62. Voss, T.C., Schiltz, R.L., Sung, M.H., Yen, P.M., Stamatoyannopoulos, J.A., Biddie, S.C., Johnson, T.A., Miranda, T.B., John, S., Hager, G.L. (2011). Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell 146, 544-554.
63. Waddell, D.S., Baehr, L.M., van den Brandt, J., Johnsen, S.A., Reichardt, H.M., Furlow, J.D., Bodine, S.C. (2008). The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am. J. Physiol. Endocrinol. Metab. 295, E785-E797.
64. Watson, L.C., Kuchenbecker, K.M., Schiller, B.J., Gross, J.D., Pufall, M.A., Yamamoto, K.R. (2013). The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals. Nat. Struct. Mol. Biol. 20, 876-883.
65. Yang, Y.H., Aeberli, D., Dacumos, A., Xue, J.R., Morand, E.F. (2009). Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper. J. Immunol. 183, 1435-1445.
66. Zhao, Q., Wang, X., Nelin, L.D., Yao, Y., Matta, R., Manson, M.E., Baliga, R.S., Meng, X., Smith, C.V., Bauer, J.A., et al. (2006). MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203, 131-140.